Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer

Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a special subtype of breast cancer in which several common diagnostic biomarkers are lost. Due to the loss of expression of receptors, treatment options for TNBC are limited. Therefore, finding safe and effective treatments for patients with TNBC is a major ob...

Full description

Bibliographic Details
Main Authors:	Mei-Ren Pan, Cheng-Che Wu, Jung-Yu Kan, Qiao-Lin Li, Shu-Jyuan Chang, Chun-Chieh Wu, Chung-Liang Li, Fu Ou-Yang, Ming-Feng Hou, Hon-Kan Yip, Chi-Wen Luo
Format:	Article
Language:	English
Published:	MDPI AG 2019-12-01
Series:	Cancers
Subjects:	cytokine induced killer cells (cik) focal adhesion kinase (fak) apoptosis cytotoxicity programmed death-ligand 1 (pd-l1) triple-negative breast cancer (tnbc)
Online Access:	https://www.mdpi.com/2072-6694/12/1/94

Similar Items

Atezolizumab potentiates Tcell-mediated cytotoxicity and coordinates with FAK to suppress cell invasion and motility in PD-L1+ triple negative breast cancer cells
by: Nishant Mohan, et al.
Published: (2019-09-01)

Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells
by: Roberta Sommaggio, et al.
Published: (2020-01-01)

IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells
by: Damiano Cosimo Rigiracciolo, et al.
Published: (2020-04-01)

CD300LG improves the cytotoxic activity of CIK
by: Qiuyue Wang, et al.
Published: (2017-08-01)

PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer
by: Zi-Qi Zhou, et al.
Published: (2019-08-01)

PD-L1 expression in triple-negative breast cancer: a cross-sectional study in a Polish population
by: Łukasz Szylberg, et al.
Published: (2021-02-01)

Safety and activity of PD-1 blockade-activated DC-CIK cells in patients with advanced solid tumors
by: Chang-Long Chen, et al.
Published: (2018-04-01)

Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies
by: Frederic Carsten Schmeel, et al.
Published: (2014-08-01)

Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
by: Damiano Cosimo Rigiracciolo, et al.
Published: (2019-02-01)

Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab
by: Luciana Molinero, et al.
Published: (2019-10-01)

FAK Signaling in Rhabdomyosarcoma
by: Clara Perrone, et al.
Published: (2020-11-01)

Tyrosine phosphorylation of cortactin by the FAK-Src complex at focal adhesions regulates cell motility
by: Wang Wenqi, et al.
Published: (2011-11-01)

Structure-Based Virtual Screening, Synthesis and Biological Evaluation of Potential FAK-FAT Domain Inhibitors for Treatment of Metastatic Cancer
by: Sahar B. Kandil, et al.
Published: (2020-07-01)

Advanced Renal-Cell Carcinoma Pseudoprogression After Combined Immunotherapy: Case Report and Literature Review
by: Xiaojie Zhang, et al.
Published: (2021-05-01)

Innovative Clinical Perspectives for CIK Cells in Cancer Patients
by: Martino Introna, et al.
Published: (2018-01-01)

Biological Characteristics and Antitumor Activity of CIK Cells Activated by Recombinant Human Fibronectin for Human Lung Cancer Cell Lines In Vitro
by: Jialing WANG, et al.
Published: (2010-04-01)

Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer
by: Jie Shen, et al.
Published: (2018-07-01)

The Anticancer Power of the Immune System – New Perspectives for Patients with Triple-Negative Breast Cancer
by: Katarzyna Rygiel
Published: (2019-11-01)

Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models
by: Roberto R. Rosato, et al.
Published: (2018-09-01)

FAK is Required for Tumor Metastasis-Related Fluid Microenvironment in Triple-Negative Breast Cancer
by: Mei-Ren Pan, et al.
Published: (2019-01-01)

Function of CikA in the cyanobacterial circadian system: the pseudo-receiver domain of CikA regulates the circadian input pathway
by: Zhang, Xiaofan
Published: (2006)

Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients
by: Gerardo Botti, et al.
Published: (2017-02-01)

Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer
by: Joe Yeong, et al.
Published: (2019-02-01)

A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery
by: Mahdi Abdoli Shadbad, et al.
Published: (2021-08-01)

Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells
by: Estefanía Paula Juliá, et al.
Published: (2018-09-01)

The possible molecular regulation mechanism of CIK cells inhibiting the proliferation of Human Lung Adenocarcinoma NCL-H157 Cells
by: Li Dengrui, et al.
Published: (2016-01-01)

Positive correlation between programmed death ligand-1 and p53 in triple-negative breast cancer
by: Zeng Y, et al.
Published: (2019-09-01)

Involvement of the FAK Network in Pathologies Related to Altered Mechanotransduction
by: Enrica Urciuoli, et al.
Published: (2020-12-01)

FAK-Dependent Cell Motility and Cell Elongation
by: Kazuo Katoh
Published: (2020-01-01)

Effect of DC-CIK treatment on tumor markers and T cell subsets in patients with advanced ovarian cancer
by: Jie-Qun Guo, et al.
Published: (2016-10-01)

'Nizovata' knižnina prez XIII vek: Sbornici, proizvedenija i cikli v b'lgarskata i v sr'bskata tradicija
by: Miltenova Anisava
Published: (2009-01-01)

FAK displacement from focal adhesions: a promising strategy to target processes implicated in cancer progression and metastasis
by: Ioanna Antoniades, et al.
Published: (2021-01-01)

Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer
by: Biying Guo, et al.
Published: (2017-10-01)

Effect of DC-CIK in combined with chemotherapy on the immunological function in patients with advanced non-small cell lung cancer
by: Shi-Fan Zhou
Published: (2017-04-01)

Association Between BRCA Status and Triple-Negative Breast Cancer: A Meta-Analysis
by: Haixia Chen, et al.
Published: (2018-08-01)

<i>FAK</i>-Copy-Gain Is a Predictive Marker for Sensitivity to FAK Inhibition in Breast Cancer
by: Young-Ho Kim, et al.
Published: (2019-09-01)

18F-FHBG PET-CT Reporter Gene Imaging of Adoptive CIK Cell Transfer Immunotherapy for Breast Cancer in a Mouse Model
by: Li X, et al.
Published: (2020-11-01)

Remodels the Immunosuppressive Tumor Microenvironment by Combination of Bacillus Calmette–Guérin and Anti-PD-L1 in an Orthotopic Triple-Negative Breast Cancer Mouse Model
by: Lu Y, et al.
Published: (2021-03-01)

Cytokine-Induced Killer (CIK) Cells, In Vitro Expanded under Good Manufacturing Process (GMP) Conditions, Remain Stable over Time after Cryopreservation
by: Katia Mareschi, et al.
Published: (2020-05-01)

TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
by: Weiguang Liu, et al.
Published: (2019-07-01)

Cannot write session to /tmp/vufind_sessions/sess_mgujekecek7ed20afsp20p5q6j